Position in KRYS
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$64,580
+$2,945 QoQ
Shares Held
250
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caldwell Trust Co holds $97,798 across 7 Biotechnology names. KRYS ranks #1 (66.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
This page
|
250 | $64,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28 | $21,633 | |
| 3 | MRNA |
Moderna, Inc.
|
100 | $5,080 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
100 | $4,757 | |
| 5 | BNTX |
BioNTech SE
|
10 | $888 | |
| 6 | TECX |
Tectonic Therapeutic, Inc.
|
20 | $618 | |
| 7 | GNLX |
GENELUX Corp
|
100 | $242 |
All Filings in KRYS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,580 | 250 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $61,635 | 250 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $44,132 | 250 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $34,365 | 250 | Shares | Sole | 2025-09-22 | |
| 2025-03-31 | $45,075 | 250 | Shares | Sole | 2025-09-23 | |
| 2024-12-31 | $39,165 | 250 | Shares | Sole | 2025-09-24 | |
| 2024-09-30 | $45,507 | 250 | Shares | Sole | 2025-09-24 | |
| 2024-06-30 | $45,910 | 250 | Shares | Sole | 2025-09-24 | |
| No filing history on record for this holder in this stock. | ||||||